NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy
Intensive, combination chemotherapy for malignant diseases causes a profound immunosuppression, which persists for the whole treatment period and after its completion. Impairment of the NK cells status may increase the risk of severe, disseminated infections and cancer. The aim of the study was the...
Автори: | Jarosz, M, Hak, L, Wieckiewicz, J, Balcerska, A, Mysliwska, J |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Termedia Publishing House Ltd.
2009
|
Схожі ресурси
Схожі ресурси
-
Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma
за авторством: Amandeep Aujla, та інші
Опубліковано: (2019-04-01) -
Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
за авторством: Ali Ghassemi, та інші
Опубліковано: (2016-06-01) -
Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
за авторством: Miguel Enrique Cuéllar Mendoza, та інші
Опубліковано: (2024-02-01) -
Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
за авторством: Betül Sevinir, та інші
Опубліковано: (2011-03-01) -
Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia
за авторством: Betül Sevinir, та інші
Опубліковано: (2011-03-01)